GAITHERSBURG, Md., Feb. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that the management team will participate in the following upcoming investor conferences:
TD Cowen 45th Annual Health Care Conference: | |||||||||
Fireside Chat | |||||||||
Date: | Tuesday, March 4, 2025 | ||||||||
Time: | 9:10 – 9:40 a.m. Eastern Time (ET) | ||||||||
Location: | Boston, MA | ||||||||
Conference | |||||||||
Event: | Investor Meetings | ||||||||
Date: | Tuesday, March 4, 2025 | ||||||||
Leerink Partners 2025 Global Healthcare Conference: | |||||||||
Presentation | |||||||||
Date: | Tuesday, March 11, 2025 | ||||||||
Time: | 3:40 – 4:10 p.m. ET | ||||||||
Location: | Miami Beach, FL | ||||||||
Conference | |||||||||
Event: | Investor Meetings | ||||||||
Date: | Tuesday, March 11, 2025 | ||||||||
Jefferies Biotech on the Beach Summit: | |||||||||
Conference | |||||||||
Event: | Investor Meetings | ||||||||
Date: | Wednesday, March 12, 2025 | ||||||||
Location: | Miami Beach, FL | ||||||||
A webcast of the fireside chat and presentation will be available through the Events and Presentations page of the Company's website at ir.novavax.com, with replays available for 30 days after the conferences.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most significant health challenges by leveraging its scientific expertise in vaccines and its cutting-edge technology platform, including a protein-based nanoparticle and Matrix-M™ adjuvant. The Company's growth strategy is focused on building new and diversified partnerships via the out-licensing of its technology platform and vaccine assets earlier in the development process. These strategic collaborations are fueled by smart investments in a growing early-stage pipeline starting with the Company's core expertise in infectious disease and potentially expanding into other disease areas. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media
Giovanna Chandler
202-709-5563
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$7.40 |
| Daily Change: | -0.15 -1.99 |
| Daily Volume: | 3,814,881 |
| Market Cap: | US$1.200B |
May 19, 2025 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
